Tackling Increasing Instances of Pharmaceutical Product Recalls: Infiniti Research’s Pharma Industry Experts Share Critical Insights

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200318005340/en/

Tackling increasing instances of pharmaceutical recalls. (Graphic: Business Wire)

The repercussions of COVID-19 on the global manufacturing supply chain are expected to worsen over the coming months. Market intelligence experts at Infiniti Research predict the peak of the impact of coronavirus to occur mid-March. This would consequently prompt companies to temporarily curb assembly and manufacturing in the US and Europe. Over the past decade, several global companies had resorted to practices such as lean manufacturing, offshoring, and outsourcing in an effort to bring down their supply chain costs. Such cost-cutting measures indicate that when there is a supply-chain disruption, manufacturing will stop quickly because of a lack of parts. Furthermore, as the number of departures from Chinese ports show a steep decline (by at least 20%), we should brace for a major effect on manufacturing worldwide.

Want more insights on how you can ensure business sustainability and strategize to meet contingencies amidst the coronavirus outbreak? Request a free proposal for comprehensive insights from our industry experts.

About Infiniti Research

Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit:https://www.infinitiresearch.com/about-us

View source version on businesswire.com: https://www.businesswire.com/news/home/20200318005340/en/